Effect trestatin amylase inhibitor bread glycemic responses normal diabetic patients effect pancreatic alpha-amylase inhibitor trestatin bread postprandial plasma glucose insulin excursions healthy volunteers non-insulin-dependent diabetic patients dose levels trestatin starch peak values plasma glucose insulin placebo ingestion starch form bread healthy control diabetic patients trestatin insulin excretions significant reductions incremental plasma glucose areas dose-dependent fashion feasible trestatin starchy foods loss activity impairment taste positive effect trestatin glycemic insulinemic responses diabetics lack serious side effects great potential dietary treatment diabetic patients 